###begin article-title 0
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
Implication of Genetic Variants Near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in Type 2 Diabetes and Obesity in 6,719 Asians
###end article-title 0
###begin p 1
###xml 38 58 38 58 <email xmlns:xlink="http://www.w3.org/1999/xlink">maggieng@cuhk.edu.hk</email>
Corresponding author: Maggie C.Y. Ng, maggieng@cuhk.edu.hk
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
OBJECTIVE- Recent genome-wide association studies have identified six novel genes for type 2 diabetes and obesity and confirmed TCF7L2 as the major type 2 diabetes gene to date in Europeans. However, the implications of these genes in Asians are unclear.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
RESEARCH DESIGN AND METHODS- We studied 13 associated single nucleotide polymorphisms from these genes in 3,041 patients with type 2 diabetes and 3,678 control subjects of Asian ancestry from Hong Kong and Korea.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A</italic>
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2B</italic>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 188 191 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;12</sup>
###xml 194 195 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 195 205 195 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink">unadjusted</sub>
###xml 258 261 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 322 332 322 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink">unadjusted</sub>
RESULTS- We confirmed the associations of TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/CDKN2B, IGF2BP2, and FTO with risk for type 2 diabetes, with odds ratios ranging from 1.13 to 1.35 (1.3 x 10-12 < Punadjusted < 0.016). In addition, the A allele of rs8050136 at FTO was associated with increased BMI in the control subjects (Punadjusted = 0.008). However, we did not observe significant association of any genetic variants with surrogate measures of insulin secretion or insulin sensitivity indexes in a subset of 2,662 control subjects. Compared with subjects carrying zero, one, or two risk alleles, each additional risk allele was associated with 17% increased risk, and there was an up to 3.3-fold increased risk for type 2 diabetes in those carrying eight or more risk alleles. Despite most of the effect sizes being similar between Asians and Europeans in the meta-analyses, the ethnic differences in risk allele frequencies in most of these genes lead to variable attributable risks in these two populations.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS- Our findings support the important but differential contribution of these genetic variants to type 2 diabetes and obesity in Asians compared with Europeans.
###end p 6
###begin p 7
Published ahead of print at  on 13 May 2008.
###end p 7
###begin p 8
M.C.Y.N., K.S.P., and B.O. contributed equally to this work. H.K.L., J.C.N.C., and N.H.C. contributed equally to this work.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 546 551 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 553 559 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11</italic>
###xml 561 567 558 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAPN10</italic>
###xml 573 579 570 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 773 780 770 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 782 786 779 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 788 794 785 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 796 802 793 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A</italic>
###xml 807 813 804 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2B</italic>
###xml 815 822 812 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 828 831 825 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 991 997 988 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 1099 1100 1096 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 1101 1102 1098 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1197 1203 1194 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 1205 1212 1202 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 1214 1218 1211 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 1220 1226 1217 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1228 1236 1225 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 1242 1249 1239 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 1252 1253 1249 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 1254 1255 1251 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1256 1258 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1261 1264 1258 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 1337 1338 1334 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1339 1341 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 1342 1344 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 1383 1391 1380 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 1477 1478 1474 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1479 1481 1476 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 1482 1484 1479 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 2074 2087 2071 2084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8, HHEX</italic>
###xml 2089 2095 2086 2092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 2097 2103 2094 2100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2B</italic>
###xml 2109 2112 2106 2109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 2127 2134 2124 2131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 2136 2138 2133 2135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 2293 2299 2290 2296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 74 80 <span type="species:ncbi:9606">people</span>
Type 2 diabetes is a major health problem affecting more than 170 million people worldwide. In the next 20 years, Asia will be hit hardest, with the diabetic populations in India and China more than doubling (1). Type 2 diabetes is characterized by the presence of insulin resistance and pancreatic beta-cell dysfunction, resulting from the interaction of genetic and environmental factors. Until recently, few genes identified through linkage scans or the candidate gene approach have been confirmed to be associated with type 2 diabetes (e.g., PPARG, KCNJ11, CAPN10, and TCF7L2). Under the common variant-common disease hypothesis, several genome-wide association (GWA) studies on type 2 diabetes have been conducted in large-scale case-control samples. Six novel genes (SLC30A8, HHEX, CDKAL1, CDKN2A and CDKN2B, IGF2BP2, and FTO) with modest effect for type 2 diabetes (odds ratio [OR] 1.14-1.20) had been reproducibly demonstrated in multiple populations of European ancestry. Moreover, TCF7L2 was shown to have the largest effect for type 2 diabetes (1.37) in the European populations to date (2-8). Although many of these genes may be implicated in the insulin production/secretion pathway (TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, and IGF2BP2) (6,9-11), FTO is associated with type 2 diabetes through its regulation of adiposity (8,12,13). Moreover, two adjacent regions near CDKN2A/B are associated with type 2 diabetes and cardiovascular diseases risks, respectively (7,14-16). Despite the consistent associations among Europeans, the contributions of these genetic variants in other ethnic groups are less clear. Given the differences in environmental factors (e.g., lifestyle), risk factor profiles (body composition and insulin secretion/resistance patterns), and genetic background (linkage disequilibrium pattern and risk allele frequencies) between Europeans and Asians, it is important to understand the role of these genes in Asians. A recent case-control study in 1,728 Japanese subjects revealed nominal association to type 2 diabetes for variants at the SLC30A8, HHEX, CDKAL1, CDKN2B, and FTO genes but not IGF2BP2 (17). In the present large-scale case-control replication study of 6,719 Asians, we aimed to test for the association of six novel genes from GWA studies and TCF7L2, which had the largest effect in Europeans, and their joint effects on type 2 diabetes risk and metabolic traits.
###end p 10
###begin title 11
RESEARCH DESIGN AND METHODS
###end title 11
###begin p 12
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 912 914 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1288 1290 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1843 1845 1829 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 186 198 <span type="species:ncbi:9606">Participants</span>
###xml 360 368 <span type="species:ncbi:9606">patients</span>
###xml 414 417 <span type="species:ncbi:9606">men</span>
###xml 618 621 <span type="species:ncbi:9606">men</span>
###xml 781 789 <span type="species:ncbi:9606">patients</span>
###xml 822 825 <span type="species:ncbi:9606">men</span>
###xml 917 925 <span type="species:ncbi:9606">Patients</span>
###xml 1098 1106 <span type="species:ncbi:9606">patients</span>
###xml 1278 1286 <span type="species:ncbi:9606">patients</span>
###xml 1312 1320 <span type="species:ncbi:9606">patients</span>
###xml 1556 1559 <span type="species:ncbi:9606">men</span>
###xml 1759 1762 <span type="species:ncbi:9606">men</span>
All subjects were recruited from Hong Kong and Korea and of Asian ancestry. The subjects in the Hong Kong case-control study were of southern Han Chinese ancestry residing in Hong Kong. Participants for the case cohort consisting of 1,481 subjects with type 2 diabetes were selected from two sources. From the Hong Kong Diabetes Registry (18), we selected 556 patients (age 40.4 +/- 8.3 years [mean +/- SD], 33.2% men) with early-onset diabetes (age at diagnosis [AAD] </=40 years) and with positive family history of diabetes in first-degree relatives. An additional 763 case subjects (age 58.2 +/- 11.7 years, 40.9% men) were randomly selected from the same registry irrespective of age at diagnosis (AAD). From the Hong Kong Family Diabetes Study, 162 unrelated type 2 diabetic patients (age 41.8 +/- 11.6 years, 38.9% men), of whom 115 had early-onset familial diabetes, were also selected as case subjects (19). Patients with classic type 1 diabetes with acute ketotic presentation or continuous requirement of insulin within 1 year of diagnosis were excluded. The inclusion of young diabetic patients with familial history may increase genetic loading of the study population. Despite our previous findings suggesting up to 14% presence of monogenic diabetes in the young patients (20), 50% of these young patients were obese, mimicking the predominant feature of type 2 diabetes. The control subjects consisted of 1,530 subjects with normal glucose tolerance (fasting plasma glucose [FPG] <6.1 mmol/l). Of these, 589 (age 41.4 +/- 10.5 years, 44.7% men) were recruited from the general population participating in a community-based cardiovascular risk screening program and from hospital staff. We recruited 941 subjects (age 15.3 +/- 1.9 years, 46.8% men) from a population-based cardiovascular risk screening program for adolescents (21). Informed consent was obtained for each participating subject. This study was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong.
###end p 12
###begin p 13
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
The Korea Seoul National University Hospital (SNUH) case-control population consisted of 761 unrelated patients with type 2 diabetes registered at the Diabetes Clinic of SNUH and 632 nondiabetic control subjects. Type 2 diabetes was diagnosed using the World Health Organization (WHO) criteria (22). Subjects positive for glutamic acid decarboxylase antibodies were excluded. Nondiabetic control subjects were selected according to the following criteria: >/=60 years old, no history of diabetes, no first-degree relatives with diabetes, FPG <6.1 mmol/l, and A1C <5.8%. The Institutional Review Board of the Clinical Research Institute in SNUH approved the study protocol, and informed consent for genetic analysis was obtained from each subject.
###end p 13
###begin p 14
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 597 599 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 861 862 857 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
The Korean Health and Genome Study (KHGS) case-control population were selected from a prospective community-based epidemiology study in the Ansung (rural) and Ansan (urban) communities (23). In this study, eligible subjects aged between 40 and 69 years were examined at baseline in 2001-2002 for demographic and glucose tolerance and then followed up biannually. At baseline, 799 subjects who were on treatment for type 2 diabetes or with FPG >/=7 mmol/l or 2-h plasma glucose >/=11.1 mmol/l during a 75-g oral glucose tolerance test (OGTT) were selected as case subjects using the WHO criteria (22). For each case subject, approximately two sex-matched subjects without family history of diabetes and with normal glucose level at OGTT (FPG <7 mmol/l and 2-h plasma glucose <7.8 mmol/l) at both baseline and follow-up visits were selected as control subjects (n = 1,516). The case and control groups were frequency matched for age. The study protocol was approved by the Ethics Committee of the KHGS and Ajou University Medical Center.
###end p 14
###begin p 15
###xml 61 62 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 106 108 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 247 249 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
In all studies, general obesity was defined as BMI >/=25 kg/m2, which was modified for Asian populations (24). Among the control subjects, 434 subjects from Hong Kong and 1,516 subjects from KHGS studies underwent a 75-g OGTT to exclude diabetes (22). Moreover, 548, 609 and 1,505 subjects from the Hong Kong, SNUH, and KHGS studies, respectively, were measured for both FPG and insulin to derive surrogate indexes for insulin secretion and sensitivity.
###end p 15
###begin title 16
Clinical studies.
###end title 16
###begin p 17
###xml 453 455 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
All study subjects were examined in the morning after an overnight fast. Anthropometric parameters and blood pressure were measured. Fasting blood samples were collected for measurement of plasma glucose, insulin, and lipids. Using the homeostasis model assessment (HOMA), insulin resistance index (HOMA-IR) was assessed as fasting insulin (mU/l) x FPG (mmol/l)/22.5; and beta-cell function (HOMA-beta) was assessed as fasting insulin x 20/(FPG - 3.5) (25).
###end p 17
###begin title 18
Gene and single nucleotide polymorphism selection.
###end title 18
###begin p 19
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 373 374 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 374 375 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 595 603 595 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 737 744 737 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 848 849 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 849 850 849 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Six novel genes identified through recent GWA studies and TCF7L2 showing reproducible association to type 2 diabetes in Europeans were selected for replication study (Supplementary Table 1, which is detailed in the online appendix [available at ]) (3-8). For genes with multiple associated single nucleotide polymorphisms (SNPs), the pairwise linkage disequilibrium D' and r2 were assessed using Haploview (v.3.32) (26). Only representative SNPs with r2 <0.8 based on HapMap Han Chinese and Japanese data were selected for genotyping. Two representative SNPs (rs1333040 and rs10757278) close to CDKN2A/B that were associated with coronary heart disease and myocardial infraction were also selected (7,14-16). Genotyping of rs13266634 at SLC30A8 failed in the KHGS samples and was replaced by rs3802177, which is in complete linkage disequilibrium (r2 = 1) with rs13266634. The genotyping method and quality control for the 13 studied SNPs were shown in the online appendix.
###end p 19
###begin title 20
Statistical analyses.
###end title 20
###begin p 21
For disease association analyses, genotype frequencies for case and control subjects in each of the three study population were compared using logistic regression under a log additive model in PLINK (v.0.99, ). ORs with 95% CIs are presented with respect to the risk allele in the combined samples. For genes with multiple SNPs, haplotypes with frequencies >5% were compared in case-control samples using omnibus test implemented in PLINK. Possible independent SNP effect was assessed by conditional omnibus analysis after controlling for a significant SNP. An insignificant test suggests the presence of a single- rather than multiple-association signal at the haplotype.
###end p 21
###begin p 22
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Meta-analysis of type 2 diabetes association for the combined samples from the three study populations was performed by the fixed effects Cochran-Mantel-Haenszel (CMH) test implemented in PLINK to estimate a summary allelic OR, using study population as a strata. To correct for multiple comparisons, 10,000 permutations of case-control labels were performed in PLINK to assess for experiment-wise empirical P values. The effect of additional covariates on type 2 diabetes association was tested using logistic regression with adjustment for BMI, age, and sex in individual samples and further adjustment for study population in combined samples.
###end p 22
###begin p 23
###xml 293 294 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 804 805 800 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Continuous data were expressed as means +/- SD. BMI, insulin, and HOMA indexes were transformed by natural logarithm to normality. Each trait was winsorized at +/-4 SD from the mean to reduce the impact of outliers, which represented 0-0.5% of the data. The values were further transformed to Z scores with adjustment for age and sex and then combined and analyzed under an additive model using linear regression. For quantitative trait association analyses in the combined control samples, trait values from four groups, including the adolescents and adults from Hong Kong, Korea SNUH, and KHGS populations, were transformed separately before merging to account for population differences in trait distributions. For each trait, 5,000 permutations were performed to assess for experiment-wise empirical P values using PLINK.
###end p 23
###begin p 24
###xml 638 644 638 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 938 944 938 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
We tested for model fit for type 2 diabetes association tests by comparing additive, dominant, and recessive models using logistic regression (1 degree of freedom [df] tests) in the combined samples. Deviations from the additive model were assessed by testing the significance of dominance effect in a general (2 df) model that include an additive effect. To test for joint and interaction effects of the seven genes, a representative significant SNP from each gene was selected. Each pairwise SNP interaction was then tested in a logistic regression model that included the main effects of all seven SNPs under an additive model (except TCF7L2 for a dominant model due to the small number of homozygous risk allele carriers). By assuming similar effect size, the joint effect of the seven SNPs for type 2 diabetes risk was assessed by calculating the OR with respect to the number of risk alleles carried under an additive model (except TCF7L2 for a dominant model). The significance of the trend was assessed by logistic regression for type 2 diabetes using the categories of risk allele carried as an independent variable.
###end p 24
###begin p 25
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 314 315 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 586 587 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 638 639 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 640 641 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 645 646 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 661 662 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 662 663 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 668 669 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 706 707 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
We also compared the effect size of these risk alleles between Asians and Europeans. For type 2 diabetes association, genotype counts for SNPs in the seven genes in type 2 diabetic case and control subjects were directly obtained or estimated from the five European GWA studies and a Japanese replication study (3-8,17). Meta-analyses of type 2 diabetes association for the five European samples, four Asian samples (including three samples from the current study), and the combined European and Asian samples were performed by the CMH test. Attributable risk was calculated as (x - 1)/x. The study assumed a log additive model, x = (1 - f)2 + 2f(1 - f)gamma + f2gamma2 where gamma is the estimated OR and f is the risk allele frequency.
###end p 25
###begin p 26
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 230 231 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 1012 1013 1012 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
For meta-analysis for the association of FTO and BMI, the A allele of rs9939609 and G allele of rs9930506 were used as surrogates for the risk A allele of rs8050136 in Europeans because they are in strong linkage disequilibrium (r2 = 0.84-1) in a HapMap population of Utah residents with northern and western European ancestry (CEU population). Means and SDs were directly obtained for rs9939609 or estimated for rs9930506 genotypes from two European studies (nondiabetic control subjects and adult and older adult populations from Frayling et al. [12] and Sardinia and European American populations from Scuteri et al. [13], respectively) and for the rs8050136 genotypes from two Asian studies (17,27) and the present four samples (adolescents and adults from Hong Kong, Korea SNUH, and KHGS control subjects). Standardized mean difference (SMD), the difference between two genotypic means divided by the pooled SD, and the 95% CI for the Europeans, Asians, and combined samples were calculated with the Hedges g statistic under the fixed effects model using MedCalc for Windows, version 9.2.0.0 (MedCalc Software, Mariakerke, Belgium).
###end p 26
###begin p 27
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
In both disease and quantitative trait analyses, heterogeneity of ORs or SMDs among studies or populations was assessed by Cochran's Q statistic (28) using MedCalc (online appendix). In case of significant heterogeneity (Q statistic P < 0.1), the effect size calculated from the random effects model (DerSimonian and Laird for disease analyses) using MedCalc was also reported.
###end p 27
###begin p 28
###xml 432 435 424 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 477 483 469 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 496 497 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
All statistical tests were performed by PLINK or SAS v.9.1 (SAS Institute, Cary, NC) unless specified otherwise. Because the studied genes are well replicated and posterior power calculations (online appendix) demonstrated that the present sample size had sufficient power to detect the observed effect sizes at alpha-level of 0.05 but insufficient power at a corrected alpha-level of 0.0038 for some cases of modest effects (e.g., FTO) or rare at-risk allele frequency (e.g., TCF7L2), a nominal P value <0.05 was considered significant in this study.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin p 30
###xml 309 316 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 318 325 318 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 489 497 489 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 603 611 603 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 752 755 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;12</sup>
###xml 758 759 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 794 801 794 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 911 913 911 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 916 917 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 917 926 917 926 <sub xmlns:xlink="http://www.w3.org/1999/xlink">empirical</sub>
###xml 937 944 937 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 973 981 973 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 996 1002 996 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 1020 1023 1020 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 1109 1115 1109 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1117 1118 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1118 1119 1118 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1129 1137 1129 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 1139 1140 1139 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1140 1141 1140 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1161 1165 1161 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 1167 1168 1167 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1168 1169 1168 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1413 1419 1413 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1448 1452 1448 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 1511 1512 1511 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1635 1641 1635 1641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1646 1650 1646 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 1728 1736 1728 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 1749 1750 1749 1750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1845 1846 1845 1846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1857 1860 1857 1860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;12</sup>
###xml 1872 1879 1872 1879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 2054 2060 2054 2060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 2148 2156 2148 2156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 2171 2177 2171 2177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 2191 2195 2191 2195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 2209 2216 2209 2216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 2230 2237 2230 2237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 2256 2259 2256 2259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
We genotyped 13 representative SNPs from 7 genes implicated in type 2 diabetes in recent GWA studies in 3,041 type 2 diabetic case subjects and 3,678 nondiabetic control subjects from a Chinese population in Hong Kong and two Korean populations. The clinical characteristics of the subjects are summarized in Table 1. Table 2 showed the meta-analyses of type 2 diabetes association under a log additive model. There was no heterogeneity of ORs among the three study populations except for CDKN2A/B (rs10811661) (Q statistic P = 0.03), with a random effect OR of 1.32 (1.15-1.52). Apart from two SNPs at CDKN2A/B (rs564398 and rs1333040), all other 11 SNPs were significantly associated with type 2 diabetes, with ORs ranging from 1.09 to 1.35 (1.3 x 10-12 < P < 0.016) in the combined samples (Table 2). Eight of the 11 SNPs remained significant after adjustment for multiple comparison by permutation (1.0 x 10-4 < Pempirical < 0.012) (Table 2) despite nonsignificance of CDKN2A/B (rs10757278), TCF7L2 (rs7903146), and FTO (rs8050136). Because multiple SNPs with little or moderate linkage disequilibrium at CDKAL1 (r2 = 0.56), CDKN2A/B (r2 = 0.002-0.31), and HHEX (r2 = 0.25-0.55) were studied (Supplementary Table 2), we examined haplotype associations but did not reveal more significant association than single marker analyses (Supplementary Table 3). Further haplotype analyses by conditioning rs7756992 on CDKAL1 haplotypes and rs7923837 on HHEX haplotypes revealed no significant residual associations (P > 0.05; data not shown), suggesting that these two SNPs are sufficient to explain the respective multiple associations at CDKAL1 and HHEX. Although residual association was observed after conditioning rs10811661 on CDKN2A/B haplotypes (P = 0.023), the much stronger single marker association of rs10811661 compared with rs10757278 (P = 1.3 x 10-12 vs. 0.015; Table 2) suggests the former is the key associated SNP. Taken together, seven key SNPs from these genes were significant without correction for multiple comparisons. In this regard, TCF7L2 (rs7903146) showed the strongest effect on type 2 diabetes risk (OR 1.35), followed by CDKN2A/B (rs10811661), CDKAL1 (rs7756992), HHEX (rs7923837), IGF2BP2 (rs4402960), SLC30A8 (rs13266634), and FTO (rs8050136). These seven SNPs were further examined in the subsequent analyses.
###end p 30
###begin p 31
###xml 346 349 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 399 400 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 481 488 481 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
The association for type 2 diabetes was also tested by adjustment for BMI, age, sex, and/or study population in both individual and combined samples. Most SNPs showed similar effect sizes with or without adjustment for covariates in both individual (data not shown) and combined samples. However, the association for type 2 diabetes was lost for FTO (rs8050136) after covariate adjustment (OR 1.13, P = 0.016 vs. 1.09, P = 0.13 with or without adjustment in the combined samples) (Table 2; Supplementary Table 4).
###end p 31
###begin p 32
###xml 133 136 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 198 205 198 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 244 245 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 311 318 309 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 323 329 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 366 367 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 427 428 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 453 460 451 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 477 480 475 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 559 560 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 560 569 558 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">empirical</sub>
We further examined the association of the seven SNPs with quantitative traits in the combined control samples. The risk A allele of FTO was significantly associated with increased BMI (P = 0.008) (Table 3) and obesity defined as BMI >/=25 kg/m2 (OR [95% CI] 1.18 [1.01-1.39]). In addition, the risk alleles at SLC30A8 and TCF7L2 were associated with increased FPG (P = 0.023) and decreased insulin at 120 min during the OGTT (P = 0.038), respectively (Table 3). However, only FTO (rs8050136) showed trend of association after multiple comparison correction (Pempirical = 0.057). None of the SNPs showed significant associations with insulin secretion (HOMA-beta) or insulin sensitivity (HOMA-IR).
###end p 32
###begin p 33
###xml 256 262 256 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 447 448 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
When we tested for the best fit model, all seven SNPs did not show significant dominance effects (Supplementary Table 5); thus, the joint and interaction effects analyses were performed using an additive/multiplicative model (except the dominant model for TCF7L2). None of the pairwise SNP interactions was significant (data not shown). However, there was a significant increase in risk for type 2 diabetes with increasing number of risk alleles (P < 0.001) in gene-dosage analysis. Compared with 9% of subjects carrying zero, one, or two risk alleles, each additional risk allele was associated with 17% increased risk and up to 3.3-fold increased risk for type 2 diabetes in those 4% subjects carrying eight or more risk alleles (Supplementary Fig. 1).
###end p 33
###begin p 34
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 342 349 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t4">Table 4</xref>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t4">Table 4</xref>
We examined for ethnic differences of SNP association with type 2 diabetes and BMI using the current data and published studies (3-8,12,13,17,27). Although TCF7L2 demonstrated the strongest effect on type 2 diabetes in both Europeans (OR 1.44) and Asians (1.44), other genes had modest effect in Europeans (1.11-1.23) and Asians (1.12-1.27) (Table 4; Supplementary Fig. 2). Moreover, CDKAL1 (rs7756992) showed stronger effect sizes in Asians than in Europeans (1.26 vs. 1.14) (Table 4).
###end p 34
###begin p 35
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 727 728 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
In the meta-analysis of FTO (rs8050136) and BMI in Europeans, AC and AA genotypes were associated with an increase of 0.09 (0.07-0.11) and 0.19 (0.17-0.21) SMD of BMI, respectively, when compared with CC genotype (Supplementary Fig. 3). The respective effect was weaker in Asians, corresponding to an increase of 0.05 (-0.006 to 0.10) and 0.10 (-0.07 to 0.26) SMD of BMI, respectively, for AC and AA genotypes. The difference reached significance when comparing AC+AA with CC genotypes (SMD 0.05 [0.0001-0.11]). Although the SMDs of BMI between AC+AA and CC groups were similar in study groups within both Europeans and Asians, the effect of rs8050136 on BMI was significantly stronger in Europeans than in Asians (Q statistic P = 0.02).
###end p 35
###begin title 36
DISCUSSION
###end title 36
###begin p 37
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 748 756 748 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 958 959 958 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 960 961 960 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 962 963 962 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1048 1049 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1144 1146 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
Our study provides important insights for the impact of the new type 2 diabetes genes identified through GWA studies. To our knowledge, this is the largest replication study in Asians up to now. We confirm the type 2 diabetes association of seven representative risk alleles for these seven genes found in Europeans (3-8), suggesting many of the variants associated with type 2 diabetes in Europeans are also associated in Asians. These genetic effects seem to be additive. Despite differences in effect size of each gene, a crude estimate suggests up to 3.3-fold increased type 2 diabetes risk in subjects carrying eight or more risk alleles compared with those carrying two or fewer risk alleles (Supplementary Fig. 1). Two adjacent regions near CDKN2A/B have been reported to be associated with type 2 diabetes and cardiovascular diseases. Our data confirm the association of type 2 diabetes for rs10811661, found in the European type 2 diabetes studies (3,4,8), but not rs564398, found only in the Wellcome Trust Case Control Consortium Study (8). In addition, we found that the cardiovascular disease risk loci (rs1333040 and rs10757278) (14-16) were not associated with type 2 diabetes.
###end p 37
###begin p 38
###xml 185 192 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 200 206 200 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2B</italic>
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 1199 1206 1199 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 903 911 <span type="species:ncbi:9606">patients</span>
Our findings are further supported by a recent Japanese study on 864 case subjects and 864 control subjects that demonstrated nominal association to type 2 diabetes for variants at the SLC30A8, HHEX, CDKAL1, CDKN2B, and FTO genes with similar ORs (1.19-1.46) compared with our data (17). The lack of association at IGF2BP2 in their study was partly due to the smaller sample size. Meta-analyses of the Japanese and our data confirmed the significant associations to type 2 diabetes in all seven genes (Supplementary Fig. 2). It is of note that different ascertainment criteria were used in the present three populations. These differences in phenotypes and environmental exposure and the use of the same statistics for both matched and unmatched samples may bias the estimation of the actual effect size in the general population. For example, the Hong Kong population consisted of young-onset diabetic patients who may be contaminated by monogenic diabetes, whereas some adolescent control subjects may develop diabetes in the future. Removal of these young case and control subjects (Supplementary Table 6) resulted in similar effect sizes in both the Hong Kong and combined samples compared with Table 2.
###end p 38
###begin p 39
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 269 272 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 448 451 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
In this study, we also confirmed the association of FTO with obesity, which indirectly modulates type 2 diabetes risk as found in Europeans (8,12,13). Interestingly, both the Japanese study (17) and a Chinese study (n = 3,210) (27) failed to demonstrate association of FTO (rs8050136) with obesity or BMI. The discrepancy might be due to population-specific bias and/or insufficient power. Our meta-analysis demonstrated significant association of FTO (AC+AA vs. CC) with BMI in Asians, although their risk allele frequency and effect size were lower compared with Europeans.
###end p 39
###begin p 40
###xml 188 194 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 211 219 208 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 255 257 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 560 566 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
We were unable to demonstrate association of any genes with insulin secretion capacity in nondiabetic subjects as assessed by HOMA-beta index, in contrast with the significant findings at CDKAL1 (rs7756992) and CDKN2A/B (rs10811661) in Japanese subjects (17). HOMA-beta index is a less sensitive surrogate for beta-cell function compared with insulinogenic index derived from OGTT or hyperglycemic clamp. This will compromise the study power, which could be further reduced by the relatively low minor allele frequency in Asians for some of the genes, such as TCF7L2.
###end p 40
###begin p 41
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 314 316 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 341 347 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 520 526 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 538 545 535 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t4">Table 4</xref>
###xml 615 620 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 683 689 680 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11</italic>
###xml 799 800 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 801 802 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 803 804 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 818 820 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 821 823 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 905 906 902 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 907 908 904 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 909 911 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 912 914 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 1105 1107 1099 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 1194 1200 1188 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1202 1210 1196 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 1212 1216 1206 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 1218 1224 1212 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 1230 1233 1224 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 1306 1312 1300 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1332 1336 1326 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 1360 1366 1354 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 1462 1469 1456 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t4">Table 4</xref>
###xml 1557 1563 1551 1557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 1620 1622 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 1623 1625 1617 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
Europeans and Asians are different in their environmental risk profiles, body composition, and genetic backgrounds. In particular, Asians are at risk for type 2 diabetes at a lower level of obesity, partly due to their increased predisposition to visceral adiposity (29) and reduced pancreatic beta-cell function (30). In the meta-analyses, TCF7L2 rs7903146 showed the strongest effect (OR 1.44) in both Europeans and Asians. Moreover, the effect sizes of most risk alleles are similar in the two populations except for CDKAL1 rs7756992 (Table 4; Supplementary Fig. 2). In addition to the consistent association of PPARG Pro12Ala (ORs for Ala allele 1.14 and 1.76, respectively) and KCNJ11 Glu23Lys (OR for Lys allele 1.14 and 1.23, respectively) polymorphisms to type 2 diabetes in both Europeans (3,4,8) and Asians (31,32), many of these genes are believed to play important roles in insulin secretion (3,6,10,33). This is in keeping with the prevailing view that abnormalities in beta-cell function play a critical role in defining the risk and development of type 2 diabetes in different populations (34). On the other hand, ethnic differences in risk allele frequencies for genes, such as CDKAL1, CDKN2A/B, HHEX, TCF7L2, and FTO, may lead to differences in attributable risks (e.g., 7.9 vs. 21.6% for CDKAL1, 22.5 vs. 9.2% for HHEX, and 20.2 vs. 2.2% for TCF7L2, in Europeans vs. Asians, respectively) and thus alter their impacts on different populations (Table 4). Our previous work and that of others suggest the presence of additional risk loci at TCF7L2 for type 2 diabetes in Chinese compared with Europeans (35,36). Given the differences in linkage disequilibrium pattern and risk allele frequencies, it will be valuable to further examine these genes thoroughly to search for population-specific and/or shared culprit disease loci and the associated phenotypes in different ethnic groups.
###end p 41
###begin title 42
Supplementary Material
###end title 42
###begin title 43
Online-Only Appendix
###end title 43
###begin p 44
The Hong Kong study was supported by the Research Grant Council Central Allocation Scheme (CUHK 1/04C) and the Chinese University of Hong Kong Direct Grant (2006.1.041). The Korea SNUH study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (00-PJ3-PG6-GN07-001). The KHGS study work was supported by the intramural grant and the extramural grant of the National Institute of Health, Korea (2001: 2003-347-6111-221, 2004:347-6111-213, and 2005: 347-24002-440-215).
###end p 44
###begin p 45
We thank all study subjects participating in these three studies. For the Hong Kong study, we thank Cherry Chiu and Dr. Ying Wang for recruitment of study subjects and Lunan Chow, Kevin Yu, and Patty Tse for computing and laboratory support. We thank the Centre for Clinical Trials and the Information Technology Services Centre for computing resources support. We thank all nursing and medical staff at the Prince of Wales Hospital Diabetes and Endocrine Centre for their dedication and professionalism. For the Korea SNUH study, we thank In Suk Ha and Hyun Jung Lim for recruitment of study subjects and Mi Ok Kang for laboratory support. We thank all the staff at the Genome Research Center for Diabetes and Endocrine Disease at SNUH for their dedication and professionalism. For the KHGS study, we thank Dr. Younjhin Ahn for epidemiological study design and Seung Hun Cha, Hye Ree Han, and Min Hyung Ryu for laboratory support. We thank all staff at the Center for Clinical Epidemiology, Ajou University Medical Center for their dedication for the project.
###end p 45
###begin title 46
REFERENCES
###end title 46
###begin p 47
Clinical characterization of study populations
###end p 47
###begin p 48
Data are means +/- SD, geometric mean (95% CI), or percent.
###end p 48
###begin p 49
Associations of seven genes with type 2 diabetes in Chinese and Korean populations
###end p 49
###begin p 50
AF, allele frequency; Chr, chromosome.
###end p 50
###begin p 51
All alleles were indexed to the forward strand of NCBI Build 36. Risk alleles were defined according to association results from combined samples.
###end p 51
###begin p 52
ORs (95% CI) were reported with respect to the risk allele using a log additive model in logistic regression.
###end p 52
###begin p 53
double daggerFixed effects Cochran-Mantel-Haenszel test was shown for meta-analysis in the combined samples.
###end p 53
###begin p 54
Rs13266634 assay was failed in the Korea KHGS samples and was replaced by rs3802177.
###end p 54
###begin p 55
Associations of seven genes with metabolic traits in the combined Chinese and Korean control samples
###end p 55
###begin p 56
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
Risk alleles/non-risk alleles are indicated in the parentheses as defined according to Table 2.
###end p 56
###begin p 57
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 235 236 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 245 246 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 309 310 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
Analyses were performed by combining Z scores of age- and sex-adjusted metabolic traits in the control subjects of four populations separately and then analyzed for association by linear regression. beta values, 95% CI, and asymptotic P values (t statistic) are shown. beta value represents the difference of Z score in the trait value associated with each copy of the risk allele.
###end p 57
###begin p 58
Meta-analysis of seven genes for type 2 diabetes association in European and Asian populations
###end p 58
###begin p 59
AF, allele frequency; AR, attributable risk.
###end p 59
###begin p 60
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
Meta-analysis in Europeans was performed by fixed effects Cochran-Mantel-Haenszel test based on available SNPs in all European populations reported in the five genome-wide association studies. The SNPs included from the French study were rs13266634, rs7923837, and rs7903146 (5). The SNPs included from the Icelandic study were rs7756992, rs13266634, rs7923837, and rs7903146 (6). The SNPs included from the DGI, FUSION, and WTCCC studies were rs4402960, rs7754840, rs13266634, rs10811661, rs7903146/rs7901695, and rs8050136 (3,4,8). DerSimonian and Laird random effects OR (95% CI) for SNPs with heterogeneous between-group effects were 1.14 (1.09-1.20) for rs7756992, 1.17 (1.10-1.23) for rs13266634, 1.44 (1.30-1.59) for rs7903146, and 1.12 (1.00-1.26) for rs8050136.
###end p 60
###begin p 61
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
Meta-analysis from this study and Horikoshi et al. (17). DerSimonian and Laird random effects OR (95% CI) for SNPs with heterogeneous between-group effects was 1.29 (1.16-1.43) for rs10811661.
###end p 61
###begin p 62
Meta-analysis by combining European and Asian data.
###end p 62

